On September 11, 2026, Harvard Apparatus Regenerative Technology, Inc. completed a private placement, raising an aggregate of $2,838,911 by selling 2,703,727 shares of common stock. The Chief Executive Officer, Jerry (Junli) He, participated by purchasing shares through the conversion of bridge promissory notes. This funding supports the company's ongoing developments in regenerative medical technology.
Company Information
Company
Harvard Apparatus Regenerative Technology
Location
Holliston, Massachusetts, United States
About
Biostage, Inc. (OTCQB: formerly BSTG) changed its corporate name back to Harvard Apparatus Regenerative Technology, Inc. and began trading under the OTCQB symbol "HRGN" effective July 20, 2023. Harvard Apparatus Regenerative Technology, Inc., is a clinical stage biotechnology company that is focused on the development of organ replacement therapies using cellular scaffolds and tissue engineering to restore organ function.
Don't miss Harvard Apparatus Regenerative Technology's next move
Get an email the moment Harvard Apparatus Regenerative Technology raises, hires an exec, or expands, usually minutes after it happens.
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Harvard Apparatus Regenerative Technology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
HollistonManufacturingBiotechnologyHealth CareMedical Device